Form 8-K - Current report:
SEC Accession No. 0000939767-24-000149
Filing Date
2024-10-29
Accepted
2024-10-29 16:07:44
Documents
16
Period of Report
2024-10-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K exel-20241029.htm   iXBRL 8-K 27104
2 EX-99.1 exel20240930exhibit991.htm EX-99.1 160261
6 GRAPHIC exel-20241029_g1.jpg GRAPHIC 55431
7 GRAPHIC imagea.jpg GRAPHIC 6251
  Complete submission text file 0000939767-24-000149.txt   474502

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exel-20241029.xsd EX-101.SCH 1798
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exel-20241029_lab.xml EX-101.LAB 21885
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exel-20241029_pre.xml EX-101.PRE 12522
19 EXTRACTED XBRL INSTANCE DOCUMENT exel-20241029_htm.xml XML 2806
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Filer) CIK: 0000939767 (see all company filings)

EIN.: 043257395 | State of Incorp.: DE | Fiscal Year End: 0103
Type: 8-K | Act: 34 | File No.: 000-30235 | Film No.: 241405748
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)